Vitintra Infant

Vitintra Infant is a sterile injectable solution combining essential vitamins for infants requiring parenteral nutrition. This multivitamin supplement supports healthy growth and development in newborns. Ideal for hospital or clinical settings where intravenous nutrition is necessary. Suitable for infants with limited oral intake.

Vitintra Infant is used to provide essential vitamins to infants who cannot receive adequate nutrition through oral or enteral routes. It supports general health, immune function, and developmental needs in newborns requiring intravenous therapy. This formulation includes fat-soluble vitamins like vitamin A, D, E, and K, which are critical for early growth stages. It addresses potential deficiencies in infants with prolonged parenteral nutrition.

The vitamins in Vitintra Infant work together to support normal metabolic processes and tissue development in infants. Vitamin A supports vision and immune health, vitamin D aids calcium absorption for bone growth, vitamin E acts as an antioxidant, and vitamin K supports healthy blood clotting. These nutrients help maintain overall well-being when oral intake is insufficient. The solution is designed for gradual absorption and systemic distribution.

Vitintra Infant should only be administered under medical supervision by healthcare professionals experienced in neonatal care. Regular monitoring of vitamin levels may be required to prevent excess accumulation, particularly for fat-soluble vitamins. Ensure compatibility with other parenteral nutrition components to avoid precipitation or instability. Store in a cool, dry place away from direct light and heat.

Vitintra Infant may interact with medications affecting fat-soluble vitamin absorption or metabolism, such as certain anticonvulsants or anticoagulants. Compatibility with other intravenous solutions should be verified before mixing to prevent adverse reactions. Always consult a healthcare provider before combining with other vitamin supplements or medications. No specific drug interactions are widely documented, but professional oversight is advised.